Published in Gene Therapy Weekly, March 30th, 1998
A major source of treatment failure of gastrointestinal cancer is the development of peritoneal metastasis. A. Tsuburaya, representing colleagues from Yokohama City University and the Kanagawa Cancer Center, Japan, presented results at the 89th Annual Meeting of the American Association for Cancer Research, held March 28 - April 1, 1998, in New Orleans, Louisiana, demonstrating the effectiveness of IL-2 delivered by a defective herpes simplex virus (HSV) vector in the treatment of peritoneal tumors (abstract "Treatment of Peritoneal Metastasis by a Defective Herpes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.